Rockefeller Capital Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,850
Closed -$7K 3785
2022
Q4
$7K Hold
1,850
﹤0.01% 3240
2022
Q3
$8K Hold
1,850
﹤0.01% 3199
2022
Q2
$8K Hold
1,850
﹤0.01% 3259
2022
Q1
$9K Buy
+1,850
New +$9.9K ﹤0.01% 3121

Other funds holding ULBI

Rockefeller Capital Management's ULBI Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Ultralife (ULBI) in Q1 2023, closing a stake of 1,850 shares — an estimated $7K sold.

Rockefeller Capital Management first reported a position in ULBI in Q1 2022 and held it in 4 quarters. The position peaked at $9K in Q1 2022. 31 funds tracked by Wall St. Rank hold ULBI as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Ultralife position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,850 Ultralife shares in Q1 2023, an estimated $7K.
  • Rockefeller Capital Management first reported a position in Ultralife in Q1 2022 and held it in 4 quarters.
  • Rockefeller Capital Management's Ultralife position peaked at $9K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Ultralife as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.